Prevacid Initial Launch Efforts To Focus On Switching Prescription Users
This article was originally published in The Tan Sheet
Executive Summary
Novartis plans to prioritize converting patients currently treated with prescription Prevacid when the proton pump inhibitor becomes available over-the-counter, rather than winning over Prilosec OTC users, a Novartis executive said
You may also be interested in...
Pharma Firms Stir OTC Market, FDA Hones Enforcement: Top Stories Of 2009
Firms entering or expanding their presence in the OTC drug and nutritional product markets as part of pharmaceutical industry shuffling in 2009 attracted the attention of stakeholders already competing in those markets
Prevacid 24HR Hits Shelves, Targets Rx-Users And Fed-Up Heartburn Sufferers
Novartis supports the Nov. 12 launch of over-the-counter proton pump inhibitor Prevacid 24HR with what the firm calls its "largest OTC product launch campaign to date.
FDA Denies P&G Petition For OTC Proton Pump Inhibitor Class Labeling
FDA's rejection of a Procter & Gamble citizen petition seeking class labeling for OTC proton pump inhibitors clears a roadblock for Schering-Plough's Zegerid to potentially make an "immediate release" claim